Edition:
India

Celyad SA (CYAD.BR)

CYAD.BR on Brussels Stock Exchange

23.20EUR
16 Nov 2018
Change (% chg)

€-0.72 (-3.01%)
Prev Close
€23.92
Open
€23.74
Day's High
€23.98
Day's Low
€23.20
Volume
11,024
Avg. Vol
32,406
52-wk High
€40.85
52-wk Low
€20.20

Chart for

About

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure,... (more)

Overall

Beta: 1.65
Market Cap(Mil.): €493.66
Shares Outstanding(Mil.): 9.52
Dividend: --
Yield (%): --

Financials

BRIEF-Celyad Announces Pricing Of 47.3 Million Dollars Global Offering

* 1,276,087 ORDINARY SHARES IN EUROPE AND CERTAIN COUNTRIES OUTSIDE OF US AND CANADA IN CONCURRENT PRIVATE PLACEMENT AT PRICE OF EUR 22.29PER SHARE

17 May 2018

Earnings vs. Estimates